바이오 임피던스 애널라이저 시장 예측(-2030년) : 제품 유형별, 모달리티별, 사용 유형별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Bioimpedance Analyzers Market is accounted for $530.5 million in 2023 and is expected to reach $1087.7 million by 2030 growing at a CAGR of 10.8% during the forecast period. Bioimpedance analyzers are devices used to measure the electrical impedance of biological tissues. By applying a small electrical current to the body and measuring the resulting voltage, these analyzers estimate body composition parameters such as fat mass, lean body mass, and total body water. They are commonly used in healthcare, fitness, and research settings to assess hydration status and monitor changes in body composition over time.

According to the International Diabetes Federation (IDF) data published in 2021, globally, there were 537 million people years affected by diabetes aged between 20 to79 in 2021.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases and obesity

Bioimpedance analyzers are pivotal in assessing body composition, including fat mass, muscle mass, and hydration levels, which are critical indicators of health and disease risk. With the global rise in chronic conditions such as diabetes, cardiovascular diseases, and metabolic disorders linked to obesity, there is a growing demand for tools like bioimpedance analyzers to facilitate early detection, monitoring, and management, driving market growth.

Restraint:

High cost associated with advanced bioimpedance analyzers

The high cost associated with advanced bioimpedance analyzers represents a significant restraint in the bioimpedance analyzers market. These sophisticated devices, equipped with advanced features and capabilities, often come with a hefty price tag, limiting their accessibility to certain demographic segments and healthcare facilities. Additionally, the initial investment required for purchasing and maintaining these analyzers may deter potential buyers, especially in resource-constrained settings.

Opportunity:

Increasing adoption of bioimpedance analyzers in home healthcare settings

These devices offer users the convenience of monitoring their body composition and health parameters from the comfort of their homes, empowering individuals to take proactive measures towards better health management. With the rise of telemedicine and remote patient monitoring, bioimpedance analyzers can facilitate timely interventions and personalized care plans. Additionally, advancements in portable and user-friendly designs enhance accessibility and encourage broader adoption among consumers seeking convenient health monitoring solutions.

Threat:

Competition from alternative body composition analysis methods

Methods like dual-energy X-ray absorptiometry (DEXA) and air displacement plethysmography (ADP) offer higher precision and accuracy compared to bioimpedance analysis. While bioimpedance analyzers are convenient and non-invasive, their accuracy may be perceived as inferior in clinical and research settings. This competition challenges the market's growth by potentially diverting demand towards more established and trusted techniques, especially in applications where precise body composition measurements are critical, such as medical diagnosis and sports performance analysis.

Covid-19 Impact:

The COVID-19 pandemic has both positively and negatively impacted the bioimpedance analyzers market. While there has been increased awareness of health monitoring and fitness due to the pandemic, disruptions in manufacturing, supply chains, and healthcare services have hindered market growth. However, the market is expected to rebound as healthcare systems recover, and there is a renewed focus on preventive healthcare and remote patient monitoring post-pandemic.

The segmental body measurement segment is expected to be the largest during the forecast period

The segmental body measurement segment is anticipated to dominate the bioimpedance analyzer market throughout the forecast period. This is primarily attributed to the growing emphasis on personalized fitness and healthcare, driving the demand for precise body composition analysis. Additionally, advancements in technology have led to the development of bioimpedance analyzers capable of accurately measuring segmental body composition, allowing for targeted interventions in areas such as weight management, sports performance optimization, and disease prevention.

The multi-frequency segment is expected to have the highest CAGR during the forecast period

The multi-frequency segment is poised to exhibit significant growth in the bioimpedance analyzers market during the forecast period. This is attributed to the increasing adoption of multi-frequency bioimpedance analyzers, which offer enhanced accuracy and reliability in measuring body composition. These analyzers provide more comprehensive data by assessing various tissues and fluid compartments within the body, thus catering to the increasing demand for advanced and precise body composition analysis in healthcare, fitness, and research applications.

Region with largest share:

North America is poised to maintain its dominance in the bioimpedance analyzers market. This is primarily due to factors such as the presence of well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and increasing awareness regarding preventive healthcare measures. Additionally, ongoing research and development activities, coupled with favorable government initiatives to promote healthcare innovations, are expected to further drive market growth in the region, solidifying North America's leading position in the bioimpedance analyzers market.

Region with highest CAGR:

Asia Pacific is positioned for rapid growth in the bioimpedance analyzers market. Factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about preventive healthcare measures are driving market expansion in the region. Additionally, improving healthcare infrastructure, technological advancements, and a large population base contribute to the burgeoning demand for bioimpedance analyzers. These factors collectively propel Asia Pacific towards significant growth opportunities and a prominent position in the global bioimpedance analyzers market.

Key players in the market

Some of the key players in Bioimpedance Analyzers Market include Akern Srl, Analog Devices, BIOSPACE Co., Ltd., Bodystat Ltd., Charder Electronic Co., Ltd., ImpediMed Limited, InBody Co., Ltd., LAICA S.p.A., Maltron International Ltd., Medical Electronic Construction, Omron Healthcare, Inc., RJL Systems, Inc., seca GmbH & Co. KG, SELVAS Healthcare, Inc., Spectra Medical Devices, Inc., Tanita Corporation, Valhalla Scientific, Inc., Xiaomi and Xitron Technologies.

Key Developments:

In September 2022, Xiaomi launched an eight-electrode body composition scale that provides up to 35 body composition analysis reports. This body fat scale adopts a dual-frequency bioimpedance measurement technology to provide accurate measurements.

In April 2022, InBody, a worldwide leader in body composition technology, is pleased to announce the release of its BWA 2.0 body water analyzer. This new professional-grade device expands upon the outputs measured by the InBody S10 to provide users with more detailed insights that demonstrate how variations in body composition and body water can affect wellbeing.

In March 2022, Analog Devices launched a low-power, high-performance analog front end built for wearable bioimpedance monitoring, MAX30009. This device promised clinical-grade vital sign measurement for patient assessment.

Product Types Covered:

• Single-frequency
• Dual-frequency
• Multi-frequency

Modalities Covered:

• Wired
• Wireless

Usage Types Covered:

• Consumer-grade
• Professional-grade

Application Covered:

• Biofeedback and Training
• Body Hydration Monitoring
• Fitness and Bodybuilding
• Medical Diagnosis
• Nutritional Assessment
• Segmental Body Measurement
• Whole Body Composition Measurement

End Users Covered:

• Fitness Centers and Gyms
• Home Users
• Hospitals and Clinics
• Professional Athletes and Trainers
• Research Institutions

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Bioimpedance Analyzers Market, By Product Type

• 5.1 Introduction
• 5.2 Single-frequency
• 5.3 Dual-frequency
• 5.4 Multi-frequency

6 Global Bioimpedance Analyzers Market, By Modality

• 6.1 Introduction
• 6.2 Wired
• 6.3 Wireless

7 Global Bioimpedance Analyzers Market, By Usage Type

• 7.1 Introduction
• 7.2 Consumer-grade
• 7.3 Professional-grade

8 Global Bioimpedance Analyzers Market, By Application

• 8.1 Introduction
• 8.2 Biofeedback and Training
• 8.3 Body Hydration Monitoring
• 8.4 Fitness and Bodybuilding
• 8.5 Medical Diagnosis
• 8.6 Nutritional Assessment
• 8.7 Segmental Body Measurement
• 8.8 Whole Body Composition Measurement

9 Global Bioimpedance Analyzers Market, By End User

• 9.1 Introduction
• 9.2 Fitness Centers and Gyms
• 9.3 Home Users
• 9.4 Hospitals and Clinics
• 9.5 Professional Athletes and Trainers
• 9.6 Research Institutions

10 Global Bioimpedance Analyzers Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Akern Srl
• 12.2 Analog Devices
• 12.3 BIOSPACE Co., Ltd.
• 12.4 Bodystat Ltd.
• 12.5 Charder Electronic Co., Ltd.
• 12.6 ImpediMed Limited
• 12.7 InBody Co., Ltd.
• 12.8 LAICA S.p.A.
• 12.9 Maltron International Ltd.
• 12.10 Medical Electronic Construction
• 12.11 Omron Healthcare, Inc.
• 12.12 RJL Systems, Inc.
• 12.13 seca GmbH & Co. KG
• 12.14 SELVAS Healthcare, Inc.
• 12.15 Spectra Medical Devices, Inc.
• 12.16 Tanita Corporation
• 12.17 Valhalla Scientific, Inc.
• 12.18 Xiaomi
• 12.19 Xitron Technologies